Skip to main content
. 2018 Dec 14;9(98):37112–37124. doi: 10.18632/oncotarget.26430

Table 3A. Log rank test for survival.

H3K27 Mutant H3K27me3- H3K27Ac
Low Medium High
n # of deaths p-value n # of deaths p-value n # of deaths p-value
Total 33 21 0.283 27 15 0.798 30 3 3 14 0.294
Anatomical location
Midline 23 17 0.551 22 15 0.060 19 3 3 13 0.197
 Brainstem 9 9 n/a 8 6 0.371 6 1 1 4 0.556
 Thalamus 14 8 0.631 14 9 0.762 13 2 2 9 0.212
Non-midline 6 2 0.198 5 0 n/a 1 n/a n/a n/a n/a
 Cerebellar hemisphere 1 1 n/a 1 0 n/a n/a n/a n/a n/a n/a
 Cerebral hemisphere 5 1 0.156 4 0 n/a 1 n/a n/a 1 n/a
Gender
 Female 20 11 0.521 13 7 0.636 10 1 n/a 9 0.963
 Male 13 9 0.346 14 8 0.729 10 1 3 5 0.187
Age
 <5 years 9 5 0.035* 7 4 0.446 7 n/a 1 6 0.177
 5-10 years 6 6 0.060 6 4 0.761 5 2 1 2 0.864
 >10 years 14 8 0.598 14 7 0.295 8 1 1 6 0.253
WHO-Grade
 I 10 0 n/a 1 0 n/a 3 n/a n/a 1 n/a
 II 3 2 0.157 3 2 0.225 2 n/a 1 1 0.317
 III 10 6 0.656 10 5 0.523 6 1 1 4 0.276
 IV 15 11 0.321 13 8 0.972 11 2 1 8 0.857

n = 63, total deaths = 33 (52.38%).